A Chinese medicine compound composition with therapeutic effect on atrial fibrillation and preparation method thereof

Abstract

The invention discloses a traditional Chinese medicine compound composition having a therapeutic effect on atrial fibrillation and a preparation method thereof, which comprises the following Chinese medicine decoction pieces in parts by mass: 10-20 parts of broiled silkworm, 10-20 parts of whole scorpion, and 5 parts of amber powder ~10 parts, 10-20 parts of rehmannia root, 20-30 parts of ginseng, 10-20 parts of sophora flavescens, 10-20 parts of salvia miltiorrhiza, 5-10 parts of coptis, 20-30 parts of broiled turtle shell, 5-10 parts of cinnamon, Comfrey 10-20 parts. The present invention is aimed at the basic pathogenesis of atrial fibrillation, heart and kidney yin deficiency, internal movement of deficiency wind, internal blazing of heart fire, fighting between wind and fire, consumption of qi and yin, and occurrence of palpitations, tachycardia, and irregular pulse. Established the treatment principle of clearing heart and cooling blood, nourishing yin and dispelling wind, and the provided Chinese medicine compound has the effect of clearing heart and cooling blood, nourishing yin and dispelling wind. Clinical studies have confirmed that the Chinese medicine compound composition can significantly reduce the number of recurrences in patients with paroxysmal atrial fibrillation It can improve the clinical symptoms of atrial fibrillation such as palpitations, chest tightness, dizziness, dry mouth, bitter mouth, upset, hot hands and feet, spontaneous sweating or night sweats.

Description

technical field [0001] The invention belongs to a compound traditional Chinese medicine composition, and in particular relates to a compound traditional Chinese medicine composition capable of treating atrial fibrillation and a preparation method thereof. Background technique [0002] Atrial fibrillation (Atrial Fibrillation, Atrial Fibrillation) is a common clinical arrhythmia, its incidence rate increases rapidly with age, and it is a high risk factor for the increase of all-cause mortality, morbidity and rehospitalization rate in the population. The results of the Framingham study show that the 10-year cumulative risk of atrial fibrillation in the population exceeds 15%, 1.0% in the age group younger than 65 years old, and 26.9% in the age group older than 65 years old. Based on this, it is estimated that there are about 800 patients with atrial fibrillation in my country. 10,000 to 10 million. The risk of atrial fibrillation mainly comes from thromboembolic events and he...

AI Technical Summary

Problems solved by technology

Unfortunately, there are no clear and effective primary and secondary prevention methods for the onset of AF because the upstream mechanism of AF development is still unclear

Moreover, the long-term effectiveness of AF treatment is limited by the potential side effects of traditional antiarrhythmic drugs, the bleeding risk of long-term anticoagulation, and the high long-term recurrence rate of radiofrequency ablation

Images